WHY ACCELERATE?
of children with cancer resistant to conventional treatment die
of delay until the same new medicine already approved for adults gets approved for children
long-term survivors of childhood cancer live in Europe today. 2/3 of them experience long-term health related problems
LATEST UPDATES





